Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit
- Friday, June 16, 2023, 7:13
- Business
- Add a comment
HAMILTON, ON and BOSTON, June 16, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present in a fireside chat at the…
About the Author
adminasapcorp has written 41555 stories on this site.